Back to Search
Start Over
Risperidone in the treatment of Tourette syndrome: a retrospective case note study.
- Source :
-
Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 1996 Jan; Vol. 10 (4), pp. 317-20. - Publication Year :
- 1996
-
Abstract
- Nineteen patients with Tourette syndrome (TS) were treated with risperidone, at a mean daily dose of 1.5 mg. Of those, 41% responded positively, 35% felt that it had made no difference, while it made 24% worse. Although 53% of the patients experienced side-effects, none had extrapyramidal side-effects. At follow-up, 8 to 11 months later, only two of 19 (11 %) patients were still taking risperidone. We suggest that risperidone does have a role in a minority of TS sufferers but it is not suggested as the first line treatment. More placebo-controlled studies using risperidone are clearly indicated.
Details
- Language :
- English
- ISSN :
- 0269-8811
- Volume :
- 10
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Journal of psychopharmacology (Oxford, England)
- Publication Type :
- Academic Journal
- Accession number :
- 22302981
- Full Text :
- https://doi.org/10.1177/026988119601000411